Journal of Peking University(Health Sciences) >
Expression of hUTP14a in non-small cell lung cancer
Received date: 2018-09-27
Online published: 2019-02-26
Supported by
Supported by the National Natural Science Foundation of China(81874143)
Objective: Human U three protein 14a (hUTP14a) facilitates tumorigenesis through promoting p53 and Rb degradation as well as enhancing c-Myc oncogenic activity. Moreover, hUTP14a expression is up-regulated in human hepatocellular cancer and colorectal cancer tissues. In this study, the expression of hUTP14a in non-small cell lung cancer (NSCLC) tissues was evaluated by immunohistochemistry staining (IHC). The relationship between hUTP14a expression levels and the clinical characteristics of the NSCLC patients were analyzed. Methods: Lung cancer tissues and the adjacent non-cancerous tissues were collected from 123 cases of NSCLC patients including 53 cases of squamous cell carcinoma (SCC) and 70 cases of adenocarcinoma (ADC), who had accepted surgical resection at Peking University Third Hospital from May 2003 to April 2006. The expression level of hUTP14a was determined by IHC in human NSCLC tissues and the adjacent non-cancerous tissues. The associations between hUTP14a expression and the clinical pathological variables including gender, age, tumor size, histological type, differentiation degree and clinical pathological stage were analyzed using the Pearson’s χ 2 test. Results: The expression rate of hUTP14a in NSCLC tissues was significantly higher than that in the non-cancerous tissues (37.4% vs. 0, P<0.001). The expressions of hUTP14a in lung ADC and SCC were 48.6% and 20.6%, respectively. The expression rate of hUTP14a in both lung ADC and SCC was significantly higher than that in the adjacent non-cancerous tissues (P<0.001). In addition, the expression rate of hUTP14a in lung ADC was significantly higher than that in SCC (χ 2=8.66, P=0.003). Furthermore, the expression rate of hUTP14a in the late pTNM stage of SCC was significantly higher than that in the early pTNM stage of SCC while hUTP14a expression level was not associated with pTNM stage of ADC. No correlation was found between hUTP14a expression and the other clinical pathologic features of the patients. Conclusion: Expression of hUTP14a was up-regulated in NSCLC tissues and was correlated with pTNM stage of SCC, suggesting that hUTP14a might possess a potential as a candidate marker for the early diagnosis screening of NSCLC.
Chun-feng ZHANG , Yun LIU , Min LU , Xiao-juan DU . Expression of hUTP14a in non-small cell lung cancer[J]. Journal of Peking University(Health Sciences), 2019 , 51(1) : 145 -150 . DOI: 10.19723/j.issn.1671-167X.2019.01.025
| [1] | Zhang L, Li M, Wu N , et al. Time trends in epidemiologic cha-racteristics and imaging features of lung adenocarcinoma: a population study of 21,113 cases in China[J]. PLoS One, 2015,10(8):e0136727. |
| [2] | 王媛媛, 毕玉, 王在翔 , 等. 山东省肺癌患者生存分析[J]. 中国卫生统计, 2018,35(1):111-116. |
| [3] | 黄文彦, 刘凯珊 . 以新视角观察p53家族在肺癌发生及治疗中的独特作用[J]. 中国肺癌杂志, 2013,16(8):422-425. |
| [4] | 李相国, 齐景宪, 易明福 . P16、Rb和PCNA在非小细胞肺癌的表达及临床意义[J]. 临床肺科杂志, 2008,13(8):1002-1004. |
| [5] | Scheffner M, Huibregtse JM, Vierstra RD , et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53[J]. Cell, 1993,75(3):495-505. |
| [6] | Uchida C, Miwa S, Kitagawa K , et al. Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation[J]. EMBO J, 2005,24(1):160-169. |
| [7] | Sdek P, Ying H, Chang DL , et al. MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein[J]. Mol Cell, 2005,20(5):699-708. |
| [8] | Hu LL, Wang JN, Liu Y , et al. A small ribosomal subunit (SSU) processome component, the human U3 protein 14A (hUTP14A) binds p53 and promotes p53 degradation[J]. J Biol Chem, 2011,286(4):3119-3128. |
| [9] | Liu HJ, Wang JN, Liu Y , et al. Human U3 protein14a is a novel type ubiquitin ligase that binds RB and promotes RB degradation depending on a leucine-rich region[J]. Biochim Biophys Acta Mol Cell Res, 2018,1865(11 Pt A):1611-1620. |
| [10] | Zhang JY, Ren PW, Xu D , et al. Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc [J]. Cancer Letters, 2018, 440- 441:106-115. |
| [11] | Zhang JY, Xu D, Liu ZZ , et al. Human U three protein 14a expression is increased in hepatocellular carcinoma and associated with poor prognosis[J]. Chin Med J (Engl), 2017,130(4):470-476. |
| [12] | Ma T, Lu CX, Guo YF , et al. Human U3 protein 14a plays an anti-apoptotic role in cancer cells[J]. Bio Chem, 2017,398(11):1247-1257. |
| [13] | Groome PA, Bolejack V, Crowley JJ , et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours[J]. J Thorac Oncol, 2007,2(8):694-705. |
| [14] | Zhang Y, Xiong Y, Yarbrough WG . ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways[J]. Cell, 1998,92(6):725-734. |
| [15] | Leduc C, Claverie P, Eymin B , et al. p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation[J]. Oncogene, 2006,25(30):4147-4154. |
| [16] | Bozcuk H, Gumus A, Ozbilim G , et al. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer[J]. Med Sci Monit, 2005,11(6):11-20. |
| [17] | 张丽华, 侯振江 . p53在肺癌研究中的进展[J]. 临床肺科杂志, 2006,11(1):59-60. |
/
| 〈 |
|
〉 |